Lanzamiento Enero 2027

Ensayo controlado aleatorizado2010Financiación no declarada

Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study

Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, Casini A

International journal of food sciences and nutrition · 91 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2010-05-13 · Int J Food Sci Nutr · vol. 61 · número 8 · págs. 792–802
Editorial
Taylor & Francis
Citado
122 citas · más que el 95% de estudios similares · 4.8× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
17 trabajos
Acceso
De pago
Áreas de investigación
Liver Disease Diagnosis and Treatment · Fatty Acid Research and Health · Edible Oils Quality and Analysis
Palabras clave
Polyunsaturated fatty acid, Medicine, Adiponectin, Fatty liver, Internal medicine, Fatty acid, Gastroenterology, Food science, Disease, Biology, Biochemistry, Obesity, Insulin resistance
MeSH
liver, humans, fatty liver, enzymes, dietary fats, fatty acids, omega-3, triglycerides, plant oils, pilot projects, food, fortified, adult, aged, middle aged, female, male, adiponectin, olive oil

7 autores

  • Francesco Sofi🇮🇹 · autor de correspondenciaAzienda Ospedaliero-Universitaria Careggi; University of Florence
  • Ilaria Giangrandi🇮🇹Azienda Ospedaliero-Universitaria Careggi; University of Florence
  • Francesca Cesari🇮🇹University of Florence
  • Ilaria Corsani🇮🇹Azienda Ospedaliero-Universitaria Careggi; University of Florence
  • Rosanna Abbate🇮🇹University of Florence
  • Gian Franco Gensini🇮🇹Don Carlo Gnocchi Foundation
  • Alessandro Casini🇮🇹Azienda Ospedaliero-Universitaria Careggi; University of Florence

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background and aims

Non-alcoholic fatty liver disease (NAFLD) is a worldwide diffuse condition due to alimentary, environment and genetic factors. The aim of our preliminary study was to evaluate the effectiveness of long-term consumption of food enriched with n-3 polyunsaturated fatty acids (PUFA) in patients with NAFLD.

Methods

Eleven patients were enrolled; six (four males, two females) were planned for oral administration of 6.5 ml olive oil enriched with n-3 PUFA for 12 months, while five (four males, one female) were used as controls.

Results

Consumption of olive oil enriched with n-3 PUFA demonstrated a significant improvement of liver echo-texture and of the Doppler Perfusion Index after 12 months (after: 0.19 ± 0.02 vs. pre: 0.15 ± 0.03; P < 0.05), whereas no significant changes were seen at the end of follow-up in controls. Moreover, patients who consumed the olive oil enriched with n-3 PUFA showed a significant amelioration of liver enzymes, and of triglycerides (post: 132.8 ± 63.7 vs. pre: 164.5 ± 85.5 mg/dl; P = 0.04) in a general linear model adjusted for age and gender. Interestingly, patients reported to have a significant increase of adiponectin levels (post: 1,487.9 ± 96.7 vs. pre: 1,143 ± 24.8 μg/ml; P = 0.04).

Conclusion

The results of this preliminary study showed that long-term consumption of olive oil enriched with n-3 PUFA in patients with NAFLD is able to decrease circulating liver enzymes and triglycerides, with a significant improvement of adiponectin levels.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.